Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility
about
Aerosols transmit prions to immunocompetent and immunodeficient miceThe diverse roles of mononuclear phagocytes in prion disease pathogenesisPrion uptake in the gut: identification of the first uptake and replication sitesBiochemical properties of highly neuroinvasive prion strainsScrapie affects the maturation cycle and immune complex trapping by follicular dendritic cells in micePRNP promoter polymorphisms are associated with BSE susceptibility in Swiss and German cattleParacrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesiclesRepetitive immunization enhances the susceptibility of mice to peripherally administered prions.Bacterial colitis increases susceptibility to oral prion disease.Application of "omics" to prion biomarker discovery.Pathogenesis of chronic wasting disease in cervidized transgenic mice.Extraneural prion neuroinvasion without lymphoreticular system infection.Chronic wasting disease.Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.Resistance of neonatal mice to scrapie is associated with inefficient infection of the immature spleen.Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes.Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infectionImmunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanismStrain fidelity of chronic wasting disease upon murine adaptation.Molecular neurology of prion disease.The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection.Oral delivery of pathogens from the intestine to the nervous system.Antiprion immunotherapy: to suppress or to stimulate?Rational targeting for prion therapeutics.B cell-specific S1PR1 deficiency blocks prion dissemination between secondary lymphoid organsProgress in prion vaccines and immunotherapies.Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease SusceptibilityPrions and their lethal journey to the brain.Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis.The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.Role of CD40 in prion disease and the immune response to recombinant PrPA role for B lymphocytes in anti-infective prion therapies?Tunnelling nanotubes: a highway for prion spreading?Complement protein C3 exacerbates prion disease in a mouse model of chronic wasting disease.Cells and prions: a license to replicate.Therapeutic interventions ameliorating prion disease.Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.Determining the role of mononuclear phagocytes in prion neuroinvasion from the skin.Oral Prion Disease Pathogenesis Is Impeded in the Specific Absence of CXCR5-Expressing Dendritic Cells.
P2860
Q21089612-3A24983D-C40B-4FE0-9A9E-63C2F4D7564BQ26823101-4AAA17F8-0FCE-4B87-A752-232D17D70A6AQ27347929-FAD18153-DB93-44D1-ABAB-DFEECA763CACQ28480480-060A7107-A35D-4507-ACBC-E572DC35C392Q30973674-CBEE2D1C-9F77-4538-BE1C-3AD322AB9E85Q33282220-570683E7-E1A7-49E5-A5AC-E51A59455A51Q33425214-29CA21FF-3E39-4333-8324-5287CE92E466Q33506629-A6C12A2C-ADFD-47C8-888D-3BCD7FA2B752Q33655323-5ED42055-5A45-443E-83AF-216194CA6E7EQ33708360-9353FF36-C253-4829-AC9F-9C9BB497A1F9Q33882457-94FBCF9D-0A64-4E9A-95D5-EDAC30BB9BA1Q33987431-B03CBA78-89B6-49D6-A8A6-12C21FEC4904Q34001936-EB3B6FB8-191F-4739-B779-ED16141D5098Q34111943-2E4804EC-8399-4254-9413-B01EF00AC716Q34147720-40243DEC-405F-4470-B278-587A08A6ED25Q34233133-48F23A0E-E621-4677-AEC7-E5887539F9D8Q34388480-EBE5C5F7-D538-49DA-9996-0259118504E9Q34529687-9D791258-C5E1-4857-B2D6-1C5EBBC05599Q34648779-6E26DA49-CAC6-41BC-922A-06954EBD5BFFQ35185983-0E593A20-7E5A-442A-9CE6-27D8C6729F8FQ35488760-1788F1C8-F0F8-4706-B0E1-2D137748EB5FQ35665928-E6BF3DCB-4760-431C-A13D-7C337AF6EEBFQ35809225-0E332823-3EE4-427A-9331-FADB0AAEB31AQ35877214-461587B2-EF9C-496D-AD05-8238DEF1DA54Q35990277-93494300-3E1D-4F67-9CF2-5E19B1C61D39Q36000083-4D2C4DF5-764B-4C15-865C-55BB641651BEQ36040834-92C69B41-2CE8-45DA-895E-943AFF6492A3Q36223774-16411B9B-351E-4C19-91D7-DD14005481CAQ36389302-40D05FF8-6278-484A-826D-C103AE34B1E0Q36521947-60B7622A-6E2F-463D-B46B-4F4D7FB417FBQ36731460-CFA6EEAD-9882-426E-98A3-5756778FD745Q36747148-D6270EC8-EBAB-4853-BF72-FE00614C6BCCQ36901947-B184031C-02C6-458D-A981-445BD156FA8BQ37496462-F1BF098C-D25A-4BDD-B1C0-47DFC251DC30Q37511403-B4F9B6C7-1941-4B1E-9029-F8F129E87DB7Q37520006-DB63ABFB-F2BC-4C32-B738-F7283CC6C0DCQ37557690-C8FB9994-367A-4D3C-A3DB-388BCFB6A3C9Q38104409-B67C3FCE-2113-4DA7-AD7E-CE96DB5C3CAAQ38327168-1BE1A64D-338B-41B1-8716-903DE544428FQ38919632-5E68D060-E557-47A7-A161-4824EC85F99C
P2860
Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Follicular dendritic cell dedi ...... reduces scrapie susceptibility
@en
Follicular dendritic cell dedi ...... educes scrapie susceptibility.
@nl
type
label
Follicular dendritic cell dedi ...... reduces scrapie susceptibility
@en
Follicular dendritic cell dedi ...... educes scrapie susceptibility.
@nl
prefLabel
Follicular dendritic cell dedi ...... reduces scrapie susceptibility
@en
Follicular dendritic cell dedi ...... educes scrapie susceptibility.
@nl
P2093
P2860
P1433
P1476
Follicular dendritic cell dedi ...... reduces scrapie susceptibility
@en
P2093
Irene McConnell
Janice Young
Moira E Bruce
P2860
P304
P356
10.1128/JVI.77.12.6845-6854.2003
P407
P50
P577
2003-06-01T00:00:00Z